Skip to main content

RETRACTION article

Front. Pharmacol., 28 September 2023
Sec. Translational Pharmacology
Volume 14 - 2023 | https://doi.org/10.3389/fphar.2023.1299042
This article is part of the Research Topic Therapeutic Advances in Melatonin Research View all 7 articles

Retraction: Melatonin mediates osteoblast proliferation through the STIM1/ORAI1 pathway

This article is a retraction of:

  1. RETRACTED: Melatonin Mediates Osteoblast Proliferation Through the STIM1/ORAI1 Pathway

    1. Read original article
Frontiers Editorial Office Frontiers Editorial Office*

A Retraction of the Original Research Article
Melatonin mediates osteoblast proliferation through the STIM1/ORAI1 pathway

by Cao L, Yang K, Yuan W, Zhou S, Zhao R and Qiu S (2022). Front. Pharmacol. 13:851663. doi: 10.3389/fphar.2022.851663

The journal retracts the 2022 article cited above.

Following publication, the corresponding author contacted the editorial office stating that there are contributors that have been omitted from the authorship of the published article, despite providing substantial contributions that meet Frontiers authorship criteria. Furthermore, the corresponding author informed the editorial office about errors in data collection that affect the scientific validity of the article. It was found that the concerns were valid and that the article does not meet the standards of editorial and scientific soundness for Frontiers in Pharmacology, therefore, the article has been retracted.

This retraction was approved by the Chief Editors of Frontiers in Pharmacology and the Chief Executive Editor of Frontiers. The authors have agreed to the retraction.

Citation: Frontiers Editorial Office (2023) Retraction: Melatonin mediates osteoblast proliferation through the STIM1/ORAI1 pathway. Front. Pharmacol. 14:1299042. doi: 10.3389/fphar.2023.1299042

Received: 22 September 2023; Accepted: 22 September 2023;
Published: 28 September 2023.

Approved by:

Alastair George Stewart, The University of Melbourne, Australia

Copyright © 2023 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Frontiers Editorial Office, research.integrity@frontiersin.org

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.